- Home
- TME vs MRNA Comparison
TME vs MRNA Comparison
Compare TME & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TME
- MRNA
- Stock Information
- Founded
- TME N/A
- MRNA 2010
- Country
- TME China
- MRNA United States
- Employees
- TME N/A
- MRNA N/A
- Industry
- TME Broadcasting
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TME Consumer Discretionary
- MRNA Health Care
- Exchange
- TME Nasdaq
- MRNA Nasdaq
- Market Cap
- TME 19.5B
- MRNA 16.5B
- IPO Year
- TME 2018
- MRNA 2018
- Fundamental
- Price
- TME $11.73
- MRNA $38.83
- Analyst Decision
- TME Strong Buy
- MRNA Hold
- Analyst Count
- TME 13
- MRNA 18
- Target Price
- TME $13.11
- MRNA $79.50
- AVG Volume (30 Days)
- TME 7.3M
- MRNA 7.6M
- Earning Date
- TME 11-12-2024
- MRNA 11-07-2024
- Dividend Yield
- TME 1.16%
- MRNA N/A
- EPS Growth
- TME 27.13
- MRNA N/A
- EPS
- TME 0.54
- MRNA N/A
- Revenue
- TME $3,968,351,267.00
- MRNA $5,081,000,000.00
- Revenue This Year
- TME $3.74
- MRNA N/A
- Revenue Next Year
- TME $9.25
- MRNA N/A
- P/E Ratio
- TME $20.75
- MRNA N/A
- Revenue Growth
- TME N/A
- MRNA N/A
- 52 Week Low
- TME $8.15
- MRNA $35.80
- 52 Week High
- TME $15.77
- MRNA $170.47
- Technical
- Relative Strength Index (RSI)
- TME 50.21
- MRNA 39.50
- Support Level
- TME $11.27
- MRNA $41.06
- Resistance Level
- TME $13.83
- MRNA $44.38
- Average True Range (ATR)
- TME 0.48
- MRNA 2.43
- MACD
- TME -0.05
- MRNA 0.29
- Stochastic Oscillator
- TME 22.30
- MRNA 16.93
About TME Tencent Music Entertainment Group each representing two
Tencent Music is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.